Patients with type 2 diabetes who achieve reduced postprandial glucose levels during insulin intensive therapy may have a better recovery of β-cell function.
Ping ChenQi SunLiying XuFengfei LiHao Liu
Published in: Diabetes research and clinical practice (2024)
Drug-naïve T2D patients with lower postprandial glucose concentration during CSII therapy exhibit better β-cell function recovery.